- Report
- January 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1208EUR$1,250USD£1,038GBP
- Report
- January 2022
- 200 Pages
Global
From €7251EUR$7,500USD£6,228GBP
- Report
- May 2022
- 65 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Report
- May 2022
- 35 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Report
- May 2022
- 44 Pages
Global
From €1934EUR$2,000USD£1,661GBP
The Skin Infection Drug market is a subset of the Infectious Diseases Drugs market, which focuses on the treatment of skin infections caused by bacteria, fungi, and viruses. These drugs are used to treat a variety of skin infections, including acne, athlete's foot, impetigo, and ringworm. Commonly prescribed drugs include antibiotics, antifungals, and antivirals. In addition, topical creams, ointments, and lotions are often used to treat skin infections.
The Skin Infection Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Novartis, Sanofi, Johnson & Johnson, and Bayer. Show Less Read more